Synergistic effect of two combinations of antituberculous drugs against Mycobacterium tuberculosis
- 31 May 2012
- journal article
- Published by Elsevier BV in Tuberculosis
- Vol. 92 (3), 260-263
- https://doi.org/10.1016/j.tube.2012.01.005
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosisInternational Journal of Antimicrobial Agents, 2005
- Moxifloxacin-containing Regimens of Reduced Duration Produce a Stable Cure in Murine TuberculosisAmerican Journal of Respiratory and Critical Care Medicine, 2004
- Fluoroquinolones, tuberculosis, and resistanceThe Lancet Infectious Diseases, 2003
- Synergic activity of fluoroquinolones and linezolid against Mycobacterium tuberculosisInternational Journal of Antimicrobial Agents, 2003
- Activity of a new class of isonicotinoylhydrazones used alone and in combination with isoniazid, rifampicin, ethambutol, para-aminosalicylic acid and clofazimine against Mycobacterium tuberculosisJournal of Antimicrobial Chemotherapy, 2002
- Effectiveness of Once-Weekly Rifapentine and Moxifloxacin Regimens against Mycobacterium tuberculosis in MiceAntimicrobial Agents and Chemotherapy, 2001
- In vitro, ex-vivo and in vivo activities of ethambutol and sparfloxacin alone and in combination against mycobacteriaInternational Journal of Antimicrobial Agents, 2001
- In Vitro Activities of Six Fluoroquinolones against 250 Clinical Isolates of Mycobacterium tuberculosis Susceptible or Resistant to First-Line Antituberculosis DrugsAntimicrobial Agents and Chemotherapy, 2000
- High-Dose Isoniazid Therapy for Isoniazid-Resistant Murine Mycobacterium tuberculosis InfectionAntimicrobial Agents and Chemotherapy, 1999